Literature DB >> 2746744

High failure rate of indwelling ureteral stents in patients with extrinsic obstruction: experience at 2 institutions.

S G Docimo1, W C Dewolf.   

Abstract

The indwelling ureteral stent commonly is used to bypass 2 types of obstruction: 1) intrinsic obstruction usually due to stones or ureteropelvic junction abnormalities or 2) extrinsic compression, for example by retroperitoneal tumor. To determine the success of this intervention at 2 institutions the medical records of all patients undergoing cystoscopic placement of a stent for ureteral obstruction were reviewed. Procedures were classified by several parameters, including the type and location of the ureteral obstruction, indications for stent placement and success of the procedure. Stent failure was defined arbitrarily as clinical occlusion of the stent within 30 days of placement. X-rays were reviewed as available to measure stricture length and location in patients with extrinsic obstruction. Of the procedures at Brigham and Women's Hospital in Boston, where silicone stents are used almost exclusively, 23 perforated indwelling stents placed for intrinsic obstruction were uniformly successful. In contrast, of 24 stents placed for extrinsic obstruction 11 failed (p less than 0.0005). At Beth Israel Hospital, where polyurethane stents are used most commonly, all 21 perforated indwelling stents placed for intrinsic obstruction were successful, while 9 of 22 stents placed for extrinsic obstruction failed (5 within the first 24 hours of placement, p less than 0.0005). The only parameter that seemed to be a predictor of stent failure was luminal size, and this only in silicone catheters. The reasons for this surprising failure rate of internal stents in the face of extrinsic obstruction are not known but may be related to previous studies that describe a relationship among ureteral peristalsis, venting side holes and flow rate.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2746744     DOI: 10.1016/s0022-5347(17)38729-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  31 in total

1.  [Prosthetic pyelovesical and pyelocutanous bypass. A palliative therapy concept in tumor-induced chronic hydronephprosis].

Authors:  H Loertzer; A Jurczok; S Wagner; P Fornara
Journal:  Urologe A       Date:  2003-05-27       Impact factor: 0.639

2.  Urothelial hyperplasia complicating use of metal stents in malignant ureteral obstruction.

Authors:  B Hekimoğlu; S Men; A Pinar; E Ozmen; S O Soylu; I Conkbayir; H Kaderoğlu; M Tüzün
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

3.  Comment on: Intervention to decompress the upper tracts in patients with established pelvic malignancies.

Authors:  Tim Lane; John Hines
Journal:  Ann R Coll Surg Engl       Date:  2006-05       Impact factor: 1.891

Review 4.  Interventional procedures in the upper urinary tract.

Authors:  M P Banner; P Ramchandani; H M Pollack
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Sep-Oct       Impact factor: 2.740

Review 5.  Current status of minimally invasive endoscopic management of ureteric strictures.

Authors:  Stefanos Kachrilas; Andreas Bourdoumis; Theocharis Karaolides; Stavroula Nikitopoulou; George Papadopoulos; Noor Buchholz; Junaid Masood
Journal:  Ther Adv Urol       Date:  2013-12

6.  Percutaneous nephrostomy: technical aspects and indications.

Authors:  Mandeep Dagli; Parvati Ramchandani
Journal:  Semin Intervent Radiol       Date:  2011-12       Impact factor: 1.513

Review 7.  Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction.

Authors:  Linda Hsu; Hanhan Li; Daniel Pucheril; Moritz Hansen; Raymond Littleton; James Peabody; Jesse Sammon
Journal:  World J Nephrol       Date:  2016-03-06

Review 8.  Nuclear metabolism and the regulation of the epigenome.

Authors:  Ruben Boon; Giorgia G Silveira; Raul Mostoslavsky
Journal:  Nat Metab       Date:  2020-10-12

9.  Glis1 facilitates induction of pluripotency via an epigenome-metabolome-epigenome signalling cascade.

Authors:  Linpeng Li; Keshi Chen; Tianyu Wang; Yi Wu; Guangsuo Xing; Mengqi Chen; Zhihong Hao; Cheng Zhang; Jinye Zhang; Bochao Ma; Zihuang Liu; Hao Yuan; Zijian Liu; Qi Long; Yanshuang Zhou; Juntao Qi; Danyun Zhao; Mi Gao; Duanqing Pei; Jinfu Nie; Dan Ye; Guangjin Pan; Xingguo Liu
Journal:  Nat Metab       Date:  2020-08-24

10.  Role of Preoperative Ureteric Stenting in Optimization of Patients with Retroperitoneal Tumors Associated with Obstructive Uropathy.

Authors:  Sunirmal Choudhury; Papiya Biswas; Sayak Roy; Bitan Chatterjee; Makhan Lal Saha
Journal:  Indian J Surg Oncol       Date:  2020-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.